Neogenomics (NEO) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Neogenomics (NEO) over the last 17 years, with Q4 2025 value amounting to $210.5 million.
- Neogenomics' Other Gross PP&E Adjustments rose 491.7% to $210.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $210.5 million, marking a year-over-year increase of 491.7%. This contributed to the annual value of $210.5 million for FY2025, which is 491.7% up from last year.
- Latest data reveals that Neogenomics reported Other Gross PP&E Adjustments of $210.5 million as of Q4 2025, which was up 491.7% from -$87.8 million recorded in Q3 2025.
- Neogenomics' 5-year Other Gross PP&E Adjustments high stood at $210.5 million for Q4 2025, and its period low was -$127.3 million during Q1 2022.
- For the 5-year period, Neogenomics' Other Gross PP&E Adjustments averaged around -$34.5 million, with its median value being -$97.0 million (2023).
- In the last 5 years, Neogenomics' Other Gross PP&E Adjustments crashed by 12921.74% in 2021 and then skyrocketed by 2876.05% in 2024.
- Over the past 5 years, Neogenomics' Other Gross PP&E Adjustments (Quarter) stood at $114.9 million in 2021, then grew by 17.98% to $135.5 million in 2022, then grew by 14.99% to $155.8 million in 2023, then grew by 28.76% to $200.6 million in 2024, then grew by 4.92% to $210.5 million in 2025.
- Its last three reported values are $210.5 million in Q4 2025, -$87.8 million for Q3 2025, and -$98.1 million during Q2 2025.